1. Home
  2. EXPI vs LQDA Comparison

EXPI vs LQDA Comparison

Compare EXPI & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPI
  • LQDA
  • Stock Information
  • Founded
  • EXPI 2008
  • LQDA 2004
  • Country
  • EXPI United States
  • LQDA United States
  • Employees
  • EXPI N/A
  • LQDA N/A
  • Industry
  • EXPI Real Estate
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPI Finance
  • LQDA Health Care
  • Exchange
  • EXPI Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • EXPI 1.6B
  • LQDA 1.7B
  • IPO Year
  • EXPI N/A
  • LQDA 2018
  • Fundamental
  • Price
  • EXPI $9.42
  • LQDA $17.68
  • Analyst Decision
  • EXPI Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • EXPI 1
  • LQDA 9
  • Target Price
  • EXPI $12.00
  • LQDA $27.67
  • AVG Volume (30 Days)
  • EXPI 1.1M
  • LQDA 2.6M
  • Earning Date
  • EXPI 07-31-2025
  • LQDA 08-11-2025
  • Dividend Yield
  • EXPI 1.86%
  • LQDA N/A
  • EPS Growth
  • EXPI N/A
  • LQDA N/A
  • EPS
  • EXPI N/A
  • LQDA N/A
  • Revenue
  • EXPI $4,593,157,000.00
  • LQDA $14,144,000.00
  • Revenue This Year
  • EXPI $2.90
  • LQDA $190.73
  • Revenue Next Year
  • EXPI $4.40
  • LQDA $421.01
  • P/E Ratio
  • EXPI N/A
  • LQDA N/A
  • Revenue Growth
  • EXPI 3.62
  • LQDA N/A
  • 52 Week Low
  • EXPI $6.90
  • LQDA $8.26
  • 52 Week High
  • EXPI $15.39
  • LQDA $20.33
  • Technical
  • Relative Strength Index (RSI)
  • EXPI 40.45
  • LQDA 59.54
  • Support Level
  • EXPI $10.86
  • LQDA $18.98
  • Resistance Level
  • EXPI $11.38
  • LQDA $20.33
  • Average True Range (ATR)
  • EXPI 0.50
  • LQDA 1.07
  • MACD
  • EXPI -0.11
  • LQDA 0.29
  • Stochastic Oscillator
  • EXPI 16.99
  • LQDA 57.87

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: